Pages that link to "Q24293042"
Jump to navigation
Jump to search
The following pages link to Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth (Q24293042):
Displaying 50 items.
- vascular endothelial growth factor A (Q7916455) (← links)
- Neuropilin 1 (Q21114530) (← links)
- kinase insert domain receptor (Q21172390) (← links)
- Neuropilin-2 expression in breast cancer: correlation with lymph node metastasis, poor prognosis, and regulation of CXCR4 expression (Q21260387) (← links)
- Methodology for Anti-Gene Anti-IGF-I Therapy of Malignant Tumours (Q21284986) (← links)
- The role of neuropilins in cell signalling (Q24316500) (← links)
- Neuropilin 1 (NRP1) hypomorphism combined with defective VEGF-A binding reveals novel roles for NRP1 in developmental and pathological angiogenesis (Q24318367) (← links)
- The cytoplasmic domain of neuropilin-1 regulates focal adhesion turnover (Q24324024) (← links)
- Neuropilin-1 signaling through p130Cas tyrosine phosphorylation is essential for growth factor-dependent migration of glioma and endothelial cells (Q24337623) (← links)
- Guidance molecules in lung cancer (Q24598659) (← links)
- Targeting neuropilin-1 in human leukemia and lymphoma (Q24620098) (← links)
- Small molecule inhibitors of the neuropilin-1 vascular endothelial growth factor A (VEGF-A) interaction (Q24622074) (← links)
- Neuropilin-1 identifies endothelial precursors in human and murine embryonic stem cells before CD34 expression (Q24644078) (← links)
- Neuropilin-1 antagonism in human carcinoma cells inhibits migration and enhances chemosensitivity (Q24647073) (← links)
- VEGF-B is dispensable for blood vessel growth but critical for their survival, and VEGF-B targeting inhibits pathological angiogenesis (Q24658393) (← links)
- NRP1 function and targeting in neurovascular development and eye disease (Q26765952) (← links)
- Pharmacologic resistance in colorectal cancer: a review (Q26769850) (← links)
- Wiring the Vascular Network with Neural Cues: A CNS Perspective (Q26800182) (← links)
- Lymphangiogenesis and metastasis--a closer look at the neuropilin/semaphorin3 axis (Q26825144) (← links)
- Recent applications of chemosensitivity tests for colorectal cancer treatment (Q26851075) (← links)
- Neuropilins: expression and roles in the epithelium (Q26998786) (← links)
- Extracellular regulation of VEGF: isoforms, proteolysis, and vascular patterning. (Q27000351) (← links)
- Receptor tyrosine kinase-mediated angiogenesis (Q27001612) (← links)
- Molecular control of endothelial cell behaviour during blood vessel morphogenesis (Q27007664) (← links)
- Bevacizumab treatment for advanced breast cancer (Q27027498) (← links)
- Semaphorin 3A suppresses tumor growth and metastasis in mice melanoma model (Q27306612) (← links)
- Structural studies of neuropilin/antibody complexes provide insights into semaphorin and VEGF binding (Q27648978) (← links)
- Angiogenesis and liver fibrosis (Q28082569) (← links)
- VEGF binding to NRP1 is essential for VEGF stimulation of endothelial cell migration, complex formation between NRP1 and VEGFR2, and signaling via FAK Tyr407 phosphorylation (Q28240025) (← links)
- Tie2Cre-mediated inactivation of plexinD1 results in congenital heart, vascular and skeletal defects (Q28593934) (← links)
- Wnt/beta-catenin signaling is required for CNS, but not non-CNS, angiogenesis (Q28594356) (← links)
- Heparan sulfate signaling in cancer (Q28657828) (← links)
- Neuropilin-2 mediated β-catenin signaling and survival in human gastro-intestinal cancer cell lines (Q28743682) (← links)
- Tumor angiogenesis (Q29614938) (← links)
- Molecular regulation of angiogenesis and lymphangiogenesis (Q29616150) (← links)
- A graph theoretic approach to utilizing protein structure to identify non-random somatic mutations. (Q30360645) (← links)
- Anti-vascular endothelial growth factor therapies as a novel therapeutic approach to treating neurofibromatosis-related tumors. (Q30388655) (← links)
- Neuropilin-1 stimulates tumor growth by increasing fibronectin fibril assembly in the tumor microenvironment (Q30450729) (← links)
- Normalization of the vasculature for treatment of cancer and other diseases (Q30471456) (← links)
- Neuropilin-1 promotes cirrhosis of the rodent and human liver by enhancing PDGF/TGF-beta signaling in hepatic stellate cells (Q30495328) (← links)
- Imatinib inhibits VEGF-independent angiogenesis by targeting neuropilin 1-dependent ABL1 activation in endothelial cells (Q30579734) (← links)
- VEGF/neuropilin-2 regulation of Bmi-1 and consequent repression of IGF-IR define a novel mechanism of aggressive prostate cancer (Q30595149) (← links)
- Neuropilin-1 modulates p53/caspases axis to promote endothelial cell survival (Q33305429) (← links)
- Successful inhibition of tumor development by specific class-3 semaphorins is associated with expression of appropriate semaphorin receptors by tumor cells (Q33372124) (← links)
- A phase I study of the human monoclonal anti-NRP1 antibody MNRP1685A in patients with advanced solid tumors (Q33413739) (← links)
- A Phase Ib study evaluating MNRP1685A, a fully human anti-NRP1 monoclonal antibody, in combination with bevacizumab and paclitaxel in patients with advanced solid tumors (Q33413979) (← links)
- Identification of circulating neuropilin-1 and dose-dependent elevation following anti-neuropilin-1 antibody administration (Q33523441) (← links)
- From combinatorial peptide selection to drug prototype (I): targeting the vascular endothelial growth factor receptor pathway (Q33535171) (← links)
- Alphav beta3 integrin limits the contribution of neuropilin-1 to vascular endothelial growth factor-induced angiogenesis (Q33553383) (← links)
- VEGF targets the tumour cell (Q33573324) (← links)